Navigation Links
The Electro-Nail - Better Design for Faster Healing. ICAP Ocean Tomo Announces Auction of an Advanced Electro-Nail Implant System for Electro-Magnetic Bone Stimulation in Orthopedics

CHICAGO, March 15, 2011 /PRNewswire/ -- Developed by Neue Magnetodyn and represented by ICAP Ocean Tomo, this portfolio represents the second lot available from Neue Magnetodyn that will be auctioned at ICAP Ocean Tomo's Spring 2011 Live IP Auction event March 31st in New York City. The assets of this lot disclose an advanced electro-nail implant system used for electro-magnetic bone stimulation.


Key Characteristics & BenefitsThis patent discloses the following:

  • An advanced electrically conductive interlocking nail system for treating bone fractures.
  • Termed the electro-nail, it is a perfectly standard intramedullary nail system, with an advanced configuration to facilitate quick healing at a fracture site.
  • If needed this nail can be "switched on" to become an active device that accelerates wound healing and combats infection for non-union fractures and open wounds.
  • The system comprises an intramedullary nail with an electrical coil assembly within one of the end caps. The outer contact surface of the nail is electrically conductive and acts as an electrode.
  • Since the electrical coil is placed at one end of the nail system, the introduction of the nail into the broken bone is not obstructed during a surgical operation.
  • If not included in the original procedure, the later addition of the inducible active cap is a relatively simple procedure to complete, compared to the replacement of the total nail, if an active device is called for.
  • The system also provides many biological advantages:
  • 1. Faster consolidation of the fracture.
  • 2. Improved mechanical loading capacity, and reduced risk of implant failure as the bone becomes weight bearing earlier.
  • 3. Minimized risk of infection.
  • 4. Reduced risk of delayed healing or pseudarthrosis.
  • 5. Efficient in therapy resistant pseudarthrosis and infected situations
  • The electro-nail patent on offer was developed from a well established, CE certified earlier model utilized in many successful implantations.
  • Patent coverage is broad and includes issued patents in many major territories including China.

  • Market PotentialThis lot should be of interest to manufacturers of prosthetic devices, orthopedic surgery devices, and biomaterials, and to healthcare service providers.

  • The global orthopedic implants market is forecast to grow to $41.8 billion by 2016, while the US orthopedic implants market is expected to be worth $23 billion in 2012. (1)(2)

  • To learn more about the assets available for sale in this portfolio: Contact Dean Becker of ICAP Ocean Tomo at Dean.Becker@us.icap.comAbout ICAP Ocean Tomo LLCICAP Ocean Tomo is the intellectual property brokerage division of ICAP and the world's premier patent auction firm.

    About ICAPICAP is the world's premier interdealer broker and provider of post trade services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, foreign exchange, emerging markets, equities and equity derivatives through voice and electronic networks. ICAP plc was added to the FTSE 100 Index on 30 June 2006. For more information go to

    (1) (2)

    SOURCE ICAP Ocean Tomo
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
    2. First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs
    3. Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine
    4. Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation
    5. Study Shows Once-Yearly Reclast Better than Risedronate at Increasing Bone Mass in Patients With Osteoporosis Caused by Glucocorticoids
    6. Phreesia Announces Clinical Initiative to Better Manage Symptoms of Parkinsons Disease
    7. In Blood Vessel Stents, Innovative Materials Allow Better Control, Delivery of Gene Therapy
    8. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
    9. Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM)
    10. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
    11. Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
    Post Your Comments:
    (Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
    (Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
    (Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
    Breaking Medicine Technology:
    (Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
    (Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
    (Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
    (Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
    (Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
    Breaking Medicine News(10 mins):